A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome

OBJECTIVE: Individual sensitivity to recombinant human GH (r-hGH) is variable. Identification of genetic factors contributing to this variability has potential use for individualization of treatment. The objective of this study was to identify genetic markers and gene expression profiles associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Clayton, P, Chatelain, P, Tatò, L, Yoo, H W, Ambler, G R, Belgorosky, A, Quinteiro, S, Deal, C, Stevens, A, Raelson, J, Croteau, P, Destenaves, B, Olivier, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioScientifica 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731924/
https://www.ncbi.nlm.nih.gov/pubmed/23761422
http://dx.doi.org/10.1530/EJE-13-0069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731924/
https://www.ncbi.nlm.nih.gov/pubmed/23761422
http://dx.doi.org/10.1530/EJE-13-0069

Ejemplares similares